Genentech Announces Plans to Invest $700 Million in Holly Springs, Creating 420 Jobs

mai 15, 2025

Genentech, a member of the Roche Group based in Switzerland has announced plans to invest $700 million in Holly Springs to establish a new high-volume fill/finish manufacturing facility.

“World-class companies like Genentech recognize that North Carolina is a leading state for biotechnology,” said Governor Josh Stein. “These companies know that our life science workforce is ready to help them deliver their cutting-edge medicines to the world. We are proud to welcome Genentech to North Carolina.”

In April, Genentech announced plans to invest $50 billion in new state-of-the-art research and development sites, new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California, plus an additional new site, now confirmed in Holly Springs, North Carolina.